Headlines

PAVmed And Snap On The List Of Winners And Losers Of Wednesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are PAVmed, Rubius Therapeutics, and Powerbridge Technologies Co., Ltd..

Rank Financial Asset Price Change Updated (EST)
1 PAVmed (PAVMW) 0.03 105.67% 2023-07-25 21:07:07
2 Rubius Therapeutics (RUBY) 0.02 22.22% 2023-07-26 13:11:07
3 Powerbridge Technologies Co., Ltd. (PBTS) 0.36 19.3% 2023-07-25 21:11:07
4 Tilray (TLRY) 1.96 16.67% 2023-07-26 14:46:10
5 Groupon (GRPN) 7.93 15.44% 2023-07-26 14:55:29
6 Stitch Fix (SFIX) 4.57 12.72% 2023-07-26 15:14:09
7 Nikola (NKLA) 2.28 12.07% 2023-07-26 14:29:57
8 Nio (NIO) 13.21 10.91% 2023-07-26 10:43:08
9 Seanergy Maritime Holdings Corp (SHIPW) 0.03 10% 2023-07-26 15:49:09
10 Union Pacific Corporation (UNP) 236.96 9.93% 2023-07-26 14:52:17

The three biggest losers today are Snap, Rimini Street, and Predictive Oncology.

Rank Financial Asset Price Change Updated (EST)
1 Snap (SNAP) 10.42 -16.7% 2023-07-26 13:47:44
2 Rimini Street (RMNI) 2.75 -11% 2023-07-26 11:08:08
3 Predictive Oncology (POAI) 4.93 -10.85% 2023-07-26 01:43:07
4 CoStar Group (CSGP) 84.27 -8.2% 2023-07-26 14:54:14
5 PolyPid Ltd. (PYPD) 0.34 -8.04% 2023-07-26 05:15:08
6 Passage Bio (PASG) 0.87 -7.47% 2023-07-25 19:55:32
7 SG Blocks (SGBX) 1.15 -7.26% 2023-07-26 15:23:08
8 PainReform Ltd. (PRFX) 7.45 -6.76% 2023-07-26 03:08:07
9 DISH Network (DISH) 7.21 -6.61% 2023-07-26 14:54:21
10 Qurate Retail (QRTEA) 1.02 -6.42% 2023-07-26 07:07:08

Winners today

1. PAVmed (PAVMW) – 105.67%

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.

NASDAQ ended the session with PAVmed rising 105.67% to $0.03 on Wednesday while NASDAQ fell 0.12% to $14,127.28.

Moving Average

PAVmed’s worth is way under its 50-day moving average of $0.21 and way below its 200-day moving average of $1.66.

More news about PAVmed.

2. Rubius Therapeutics (RUBY) – 22.22%

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Rubius Therapeutics rising 22.22% to $0.02 on Wednesday while NASDAQ dropped 0.12% to $14,127.28.

Earnings Per Share

As for profitability, Rubius Therapeutics has a trailing twelve months EPS of $-1.79.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -185.31%.

More news about Rubius Therapeutics.

3. Powerbridge Technologies Co., Ltd. (PBTS) – 19.3%

Powerbridge Technologies Co., Ltd. provides software application and technology solutions and services primarily in China. The company offers Powerbridge System Solutions, which include Trade Enterprise and Trade Compliance, as well as Import & Export Loan and Insurance Processing for customers to streamline their trade operations, trade logistics, and regulatory compliance. It also provides Powerbridge Software-as-a-Service solutions, which include Logistics Service Cloud and Trade Zone Operations Cloud, as well as Inward Processed Manufacturing Cloud, Cross-Border eCommerce Cloud, and Import & Export Loan and Insurance Processing Service Cloud; and Powerbridge Blockchain-as-a-Service that comprise Compliance Blockchain Services and Supply Chain Blockchain Services. The company serves international trade businesses and manufacturers, government agencies and authorities, and logistics service and other providers. It sells its solutions and services through its direct sales organization, indirect channel partners, and strategic government partners. Powerbridge Technologies Co., Ltd. was founded in 1997 and is headquartered in Zhuhai, China.

NASDAQ ended the session with Powerbridge Technologies Co., Ltd. rising 19.3% to $0.36 on Wednesday while NASDAQ dropped 0.12% to $14,127.28.

Earnings Per Share

As for profitability, Powerbridge Technologies Co., Ltd. has a trailing twelve months EPS of $-5.31.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.24%.

Yearly Top and Bottom Value

Powerbridge Technologies Co., Ltd.’s stock is valued at $0.36 at 17:32 EST, way under its 52-week high of $66.30 and way above its 52-week low of $0.05.

More news about Powerbridge Technologies Co., Ltd..

4. Tilray (TLRY) – 16.67%

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.

NASDAQ ended the session with Tilray jumping 16.67% to $1.96 on Wednesday, following the last session’s downward trend. NASDAQ fell 0.12% to $14,127.28, after two sequential sessions in a row of gains, on what was a somewhat down trend exchanging session today.

: cannabis company tilray posts narrower loss as revenue climbs 20%Our financial performance is demonstrative of Tilray Brands’ being the leading, most diversified cannabis lifestyle and consumer packaged goods company in the world, said CEO Irwin Simon.

Tilray brands, inc. (tlry) reports break-even earnings for Q4While Tilray Brands, Inc. Has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?, Ahead of this earnings release, the estimate revisions trend for Tilray Brands, Inc. Mixed.

Earnings Per Share

As for profitability, Tilray has a trailing twelve months EPS of $-3.1.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.15%.

Yearly Top and Bottom Value

Tilray’s stock is valued at $1.96 at 17:32 EST, way under its 52-week high of $5.12 and way above its 52-week low of $1.50.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 94.4% and 61.5%, respectively.

Moving Average

Tilray’s value is above its 50-day moving average of $1.85 and way under its 200-day moving average of $2.76.

Sales Growth

Tilray’s sales growth for the next quarter is 5.5%.

More news about Tilray.

5. Groupon (GRPN) – 15.44%

Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Groupon rising 15.44% to $7.93 on Wednesday while NASDAQ fell 0.12% to $14,127.28.

Earnings Per Share

As for profitability, Groupon has a trailing twelve months EPS of $-7.32.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -285.15%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Groupon’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 47.1% and 108.8%, respectively.

More news about Groupon.

6. Stitch Fix (SFIX) – 12.72%

Stitch Fix, Inc. sells a range of apparel, shoes, and accessories through its Website and mobile application in the United States. It offers denim, dresses, blouses, skirts, shoes, jewelry, and handbags for men, women, and kids under the Stitch Fix brand. The company was formerly known as rack habit inc. and changed its name to Stitch Fix, Inc. in October 2011. Stitch Fix, Inc. was incorporated in 2011 and is headquartered in San Francisco, California.

NASDAQ ended the session with Stitch Fix jumping 12.72% to $4.57 on Wednesday, after two successive sessions in a row of losses. NASDAQ fell 0.12% to $14,127.28, after two successive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Stitch Fix has a trailing twelve months EPS of $-2.04.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -74.51%.

More news about Stitch Fix.

7. Nikola (NKLA) – 12.07%

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.

NASDAQ ended the session with Nikola rising 12.07% to $2.28 on Wednesday while NASDAQ slid 0.12% to $14,127.28.

Earnings Per Share

As for profitability, Nikola has a trailing twelve months EPS of $-1.4.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -137.05%.

Sales Growth

Nikola’s sales growth is negative 14.9% for the ongoing quarter and 37.9% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 489.1%, now sitting on 60.05M for the twelve trailing months.

Volatility

Nikola’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.49%, a positive 3.91%, and a positive 8.10%.

Nikola’s highest amplitude of average volatility was 7.51% (last week), 8.70% (last month), and 8.10% (last quarter).

Yearly Top and Bottom Value

Nikola’s stock is valued at $2.28 at 17:32 EST, way below its 52-week high of $8.97 and way above its 52-week low of $0.52.

More news about Nikola.

8. Nio (NIO) – 10.91%

NIO Inc. designs, develops, manufactures, and sells smart electric vehicles in China. It offers five and six-seater electric SUVs, as well as smart electric sedans. The company also offers power solutions, including Power Home, a home charging solution; Power Swap, a battery swapping service; Power Charger and Destination Charger; Power Mobile, a mobile charging service through charging vans; Power Map, an application that provides access to a network of public chargers and their real-time information; and One Click for Power valet service. In addition, it provides repair, maintenance, and bodywork services through its NIO service centers and authorized third-party service centers; statutory and third-party liability insurance, and vehicle damage insurance through third-party insurers; repair and routine maintenance; courtesy vehicle services; roadside assistance; data packages; and auto financing and financial leasing services. Further, the company involved in the provision of energy and service packages to its users; design and technology development activities; manufacture of e-powertrains, battery packs, and components; and sales and after sales management activities. Additionally, it offers NIO Certified, a used vehicle inspection, evaluation, acquisition, and sales service. The company was formerly known as NextEV Inc. and changed its name to NIO Inc. in July 2017. NIO Inc. was incorporated in 2014 and is headquartered in Shanghai, China.

NYSE ended the session with Nio jumping 10.91% to $13.21 on Wednesday while NYSE jumped 0.2% to $16,418.21.

Earnings Per Share

As for profitability, Nio has a trailing twelve months EPS of $-1.69.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.01%.

Volume

Today’s last reported volume for Nio is 89368400 which is 58.69% above its average volume of 56313300.

Moving Average

Nio’s value is way higher than its 50-day moving average of $8.96 and way above its 200-day moving average of $10.08.

Previous days news about Nio

  • Nio stock news: NIO shares advance again Tuesday following Monday’s 11% spike. According to FXStreet on Tuesday, 25 July, "Nio is still underperforming some of its peers like Li Auto (LI) and XPeng (XPEV), which have returned 82% and 57% year to date compared with Nio stock’s 22% gain. ", "With the 50-day SMA still trading below the 200-day SMA, Nio stock technically remains in a downtrend. "

More news about Nio.

9. Seanergy Maritime Holdings Corp (SHIPW) – 10%

NASDAQ ended the session with Seanergy Maritime Holdings Corp rising 10% to $0.03 on Wednesday, after five sequential sessions in a row of losses. NASDAQ slid 0.12% to $14,127.28, after two sequential sessions in a row of gains, on what was a somewhat down trend exchanging session today.

PE Ratio

Seanergy Maritime Holdings Corp has a trailing twelve months price to earnings ratio of 0.21. Meaning, the purchaser of the share is investing $0.21 for every dollar of annual earnings.

Yearly Top and Bottom Value

Seanergy Maritime Holdings Corp’s stock is valued at $0.03 at 17:32 EST, under its 52-week high of $0.03 and above its 52-week low of $0.03.

More news about Seanergy Maritime Holdings Corp.

10. Union Pacific Corporation (UNP) – 9.93%

Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, operates in the railroad business in the United States. The company offers transportation services for grain and grain products, fertilizers, food and refrigerated products, and coal and renewables to grain processors, animal feeders, ethanol producers, and other agricultural users; petroleum, and liquid petroleum gases; and construction products, industrial chemicals, plastics, forest products, specialized products, metals and ores, soda ash, and sand, as well as finished automobiles, automotive parts, and merchandise in intermodal containers. As of December 31, 2021, its rail network included 32,452 route miles connecting Pacific Coast and Gulf Coast ports with the Midwest and Eastern United States gateways. The company was founded in 1862 and is headquartered in Omaha, Nebraska.

NYSE ended the session with Union Pacific Corporation jumping 9.93% to $236.96 on Wednesday, after two sequential sessions in a row of losses. NYSE jumped 0.2% to $16,418.21, after five successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Union Pacific Corporation has a trailing twelve months EPS of $11.32.

PE Ratio

Union Pacific Corporation has a trailing twelve months price to earnings ratio of 20.93. Meaning, the purchaser of the share is investing $20.93 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 57.48%.

Moving Average

Union Pacific Corporation’s worth is way above its 50-day moving average of $202.09 and way higher than its 200-day moving average of $202.70.

More news about Union Pacific Corporation.

Losers Today

1. Snap (SNAP) – -16.7%

Snap Inc. operates as a technology company in North America, Europe, and internationally. The company offers Snapchat, a visual messaging application with various tabs, such as camera, visual messaging, snap map, stories, and spotlight that enable people to communicate visually through short videos and images. It also provides Spectacles, an eyewear product that connects with Snapchat and captures photos and video from a human perspective; and advertising products, including AR ads and Snap ads comprises a single image or video ads, story ads, collection ads, dynamic ads, and commercials. The company was formerly known as Snapchat, Inc. and changed its name to Snap Inc. in September 2016. Snap Inc. was founded in 2010 and is headquartered in Santa Monica, California.

NYSE ended the session with Snap dropping 16.7% to $10.42 on Wednesday, after five sequential sessions in a row of losses. NYSE jumped 0.2% to $16,418.21, after five sequential sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Snap has a trailing twelve months EPS of $-0.86.

Sales Growth

Snap’s sales growth is negative 5.2% for the present quarter and negative 1% for the next.

Volatility

Snap’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.12%, a positive 0.67%, and a positive 2.42%.

Snap’s highest amplitude of average volatility was 1.12% (last week), 1.99% (last month), and 2.42% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Snap’s stock is considered to be overbought (>=80).

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 100% and a negative 112.5%, respectively.

Previous days news about Snap

  • Snap (snap) reports Q2 loss, tops revenue estimates. According to Zacks on Tuesday, 25 July, "While Snap has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
  • Snap stock falls 15% after hours as sales forecast comes up short. According to MarketWatch on Tuesday, 25 July, "Like other social-media platforms, Snap has struggled with a slowdown in the digital ad market, amid advertiser wariness of a recession. ", "For the second quarter, Snap reported a net loss of $377 million, or 24 cents a share, compared with $422 million, or 26 cents a share, in the same quarter last year. "
  • Is a surprise coming for snap (snap) this earnings season?. According to Zacks on Monday, 24 July, "Investors are always looking for stocks that are poised to beat at earnings season and Snap (SNAP Quick QuoteSNAP – Free Report) may be one such company. ", "That is because Snap is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. "

More news about Snap.

2. Rimini Street (RMNI) – -11%

Rimini Street, Inc. provides enterprise software products, services, and support for various industries. The company offers software support services for Oracle and SAP enterprise software products. It sells its solutions primarily through direct sales organizations in North America, Latin America, Europe, Africa, the Middle East, Asia, and the Asia-Pacific. Rimini Street, Inc. was incorporated in 2005 and is headquartered in Las Vegas, Nevada.

NASDAQ ended the session with Rimini Street falling 11% to $2.75 on Wednesday, after five sequential sessions in a row of losses. NASDAQ slid 0.12% to $14,127.28, after two successive sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Rimini Street has a trailing twelve months EPS of $-0.01.

More news about Rimini Street.

3. Predictive Oncology (POAI) – -10.85%

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.

NASDAQ ended the session with Predictive Oncology falling 10.85% to $4.93 on Wednesday while NASDAQ slid 0.12% to $14,127.28.

Earnings Per Share

As for profitability, Predictive Oncology has a trailing twelve months EPS of $-6.34.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -92.54%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Predictive Oncology’s EBITDA is -1.26.

More news about Predictive Oncology.

4. CoStar Group (CSGP) – -8.2%

CoStar Group, Inc. provides information, analytics, and online marketplace services to the commercial real estate, hospitality, residential, and related professionals industries in the United States, Canada, Europe, the Asia Pacific, and Latin America. The company offers CoStar Property that provides inventory of office, industrial, retail, multifamily, hospitality, and student housing properties and land; CoStar Sales, a robust database of comparable commercial real estate sales transactions; CoStar Market Analytics to view and report on aggregated market and submarket trends; and CoStar Tenant, an online business-to-business prospecting and analytical tool that provides tenant information. It also provides Leasing, a tool to capture, manage, and maintain lease data; CoStar Lease Analysis; Public Record, a searchable database of commercially zoned parcels; CoStar Real Estate Manager, a real estate lease administration, portfolio management, and lease accounting compliance software solution; and CoStar Risk Analytics and CoStar Investment. In addition, it offers apartment marketing sites, such as ApartmentFinder.com, ForRent.com, ApartmentHomeLiving.com, WestsideRentals.com, AFTER55.com, CorporateHousing.com, ForRentUniversity.com, Apartamentos.com, and Off Campus Partners; LoopNet Premium Lister; LoopNet Diamond, Platinum, and Gold Ads; LandsofAmerica.com, LandAndFarm.com, and LandWatch.com for rural land for-sale; BizBuySell.com, BizQuest.com, and FindaFranchise.com for operating businesses and franchises for-sale; Ten-X, an online auction platform for commercial real estate; and HomeSnap, an online and mobile software platform, as well as Homes.com, a homes for sale listings site. The company was founded in 1987 and is headquartered in Washington, the District of Columbia.

NASDAQ ended the session with CoStar Group sliding 8.2% to $84.27 on Wednesday while NASDAQ fell 0.12% to $14,127.28.

Earnings Per Share

As for profitability, CoStar Group has a trailing twelve months EPS of $0.92.

PE Ratio

CoStar Group has a trailing twelve months price to earnings ratio of 91.6. Meaning, the purchaser of the share is investing $91.6 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.76%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CoStar Group’s stock is considered to be oversold (<=20).

Earnings Before Interest, Taxes, Depreciation, and Amortization

CoStar Group’s EBITDA is 247.35.

Volume

Today’s last reported volume for CoStar Group is 5935690 which is 99.68% above its average volume of 2972550.

More news about CoStar Group.

5. PolyPid Ltd. (PYPD) – -8.04%

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

NASDAQ ended the session with PolyPid Ltd. falling 8.04% to $0.34 on Wednesday, following the last session’s downward trend. NASDAQ fell 0.12% to $14,127.28, after two sequential sessions in a row of gains, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, PolyPid Ltd. has a trailing twelve months EPS of $-1.62.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -167.7%.

More news about PolyPid Ltd..

6. Passage Bio (PASG) – -7.47%

Passage Bio, Inc., a genetic medicines company, develops transformative therapies for rare monogenic central nervous system (CNS) diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase (ß-gal) for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin, or GRN, gene encoding progranulin, or PGRN, for the treatment of FTD-GRN; and PBKR03, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company also develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and PBCM06 for the treatment of Charcot-Marie-Tooth Type 2A, as well as programs for the treatment of adult CNS indication. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.

NASDAQ ended the session with Passage Bio dropping 7.47% to $0.87 on Wednesday, after five consecutive sessions in a row of losses. NASDAQ dropped 0.12% to $14,127.28, after two sequential sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Passage Bio has a trailing twelve months EPS of $-2.36.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -56.53%.

More news about Passage Bio.

7. SG Blocks (SGBX) – -7.26%

SG Blocks, Inc. designs and modifies code-engineered cargo shipping containers and purpose-built modules for commercial, industrial, and residential building construction in the United States. The company redesigns, repurposes, and convert heavy-gauge steel cargo shipping containers into SGBlocks, which are green building blocks for construction. It serves architects, landowners, builders, and developers. SG Blocks, Inc. was founded in 2007 and is headquartered in Jacksonville, Florida.

NASDAQ ended the session with SG Blocks dropping 7.26% to $1.15 on Wednesday while NASDAQ slid 0.12% to $14,127.28.

Earnings Per Share

As for profitability, SG Blocks has a trailing twelve months EPS of $-0.76.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -65.44%.

Sales Growth

SG Blocks’s sales growth for the next quarter is 6.2%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 36%, now sitting on 21.29M for the twelve trailing months.

Moving Average

SG Blocks’s worth is way higher than its 50-day moving average of $0.96 and under its 200-day moving average of $1.18.

Earnings Before Interest, Taxes, Depreciation, and Amortization

SG Blocks’s EBITDA is -7.49.

More news about SG Blocks.

8. PainReform Ltd. (PRFX) – -6.76%

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.

NASDAQ ended the session with PainReform Ltd. falling 6.76% to $7.45 on Wednesday, after three consecutive sessions in a row of losses. NASDAQ slid 0.12% to $14,127.28, after two sequential sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, PainReform Ltd. has a trailing twelve months EPS of $-7.89.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -73.5%.

Volume

Today’s last reported volume for PainReform Ltd. is 153711 which is 89.23% below its average volume of 1428280.

Yearly Top and Bottom Value

PainReform Ltd.’s stock is valued at $7.45 at 17:32 EST, way below its 52-week high of $26.41 and way higher than its 52-week low of $0.34.

More news about PainReform Ltd..

9. DISH Network (DISH) – -6.61%

DISH Network Corporation, together with its subsidiaries, provides pay-TV services in the United States. The company operates in two segments, Pay-TV and Wireless. It offers video services under the DISH TV brand; and programming packages that include programming through national broadcast networks, local broadcast networks, and national and regional cable networks, as well as regional and specialty sports channels, premium movie channels, and Latino and international programming packages. The company also provides access to movies and television shows through TV or Internet-connected devices; and dishanywhere.com and mobile applications on Internet-connected devices to view authorized content, search program listings, and remotely control certain features of their DVRs. In addition, it offers Sling TV services, including Sling domestic, Sling International, Sling Latino, Sling Orange, and Sling Blue services that require an internet connection and are available on streaming-capable devices, such as streaming media devices, TVs, tablets, computers, game consoles, and phones, as well as market SLING TV services to consumers who do not subscribe to traditional satellite and cable pay-TV services. Further, the company provides wireless subscribers consumer plans with no annual service contracts, as well as monthly service plans, including high-speed data and unlimited talk and text. The company offers receiver systems and programming through direct sales channels, as well as independent third parties, such as small retailers, direct marketing groups, local and regional consumer electronics stores, retailers, and telecommunications companies. DISH Network Corporation was founded in 1980 and is headquartered in Englewood, Colorado.

NASDAQ ended the session with DISH Network dropping 6.61% to $7.21 on Wednesday while NASDAQ slid 0.12% to $14,127.28.

Earnings Per Share

As for profitability, DISH Network has a trailing twelve months EPS of $3.42.

PE Ratio

DISH Network has a trailing twelve months price to earnings ratio of 2.11. Meaning, the purchaser of the share is investing $2.11 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.36%.

Moving Average

DISH Network’s value is above its 50-day moving average of $6.72 and way below its 200-day moving average of $11.17.

More news about DISH Network.

10. Qurate Retail (QRTEA) – -6.42%

Qurate Retail, Inc., together with its subsidiaries, engages in the video and online commerce industries in North America, Europe, and Asia. The company markets and sells various consumer products primarily through merchandise-focused televised shopping programs, Internet, and mobile applications. It also operates as an online retailer offering women's, children's, and men's apparel; and other products, such as home, accessories, and beauty products through its app, mobile, and desktop applications. The company serves approximately 200 million homes worldwide. The company was formerly known as Liberty Interactive Corporation and changed its name to Qurate Retail, Inc. in April 2018. Qurate Retail, Inc. was founded in 1991 and is headquartered in Englewood, Colorado.

NASDAQ ended the session with Qurate Retail sliding 6.42% to $1.02 on Wednesday while NASDAQ fell 0.12% to $14,127.28.

Earnings Per Share

As for profitability, Qurate Retail has a trailing twelve months EPS of $-7.18.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -135.86%.

Moving Average

Qurate Retail’s value is above its 50-day moving average of $0.98 and way below its 200-day moving average of $1.53.

More news about Qurate Retail.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *